Price Band
₹91 - ₹96
Lot Size
1200
Issue Size
₹58.57 Cr
GMP
N/A
Subscription
201.35x
Analyzing...
IPO Schedule
1
Open
18 Jun 2025
2
Close
20 Jun 2025
3
Allotment
-
4
Listing
25 Jun 2025
About Influx Healthtech
Influx Healthtech is an SME focused on providing innovative healthtech solutions. While specific details are unavailable without further information, the company likely operates in areas like telehealth, digital diagnostics, or healthcare data analytics.
Key Strengths
- High ROE of 36.98% suggests efficient capital utilization and profitability.
- Relatively low P/E ratio of 13.04 compared to industry averages could indicate undervaluation.
- Being an SME, it may have agility and responsiveness to market changes.
- Focus on healthtech, a sector with significant growth potential due to increasing healthcare needs and technological advancements.
- Potential for rapid scaling and market penetration if the company has a unique and valuable product or service.
Risk Factors
- •SME IPOs generally carry higher risk due to limited operating history and smaller scale of operations.
- •Healthtech sector is highly competitive and subject to regulatory changes.
- •Limited information available about the company's specific business model and competitive advantages makes a comprehensive risk assessment challenging.
Valuation Analysis
The IPO appears reasonably priced considering the high ROE and relatively low P/E ratio, but further due diligence is needed to assess the sustainability of these metrics and the company's long-term growth prospects.
IPO Details
ExchangeNSE
SegmentSME
ISININE0MYZ01012
NSE SymbolINFLUX
Face Value₹10
Lot Size1200
Issue Size₹58.57 Cr
Key Metrics
ROE36.98%
ROCE49.17%
P/E Ratio13.04
Industry P/E20
EPS7.36
PAT Margin12.75%
Debt/Equity0.01
Growth & Quality
ProfitableYes ✓
Subscription
Total5.89x
Imbalance Ratio1.0x
Documents
RHP not available
Key Dates
Open Date18 Jun 2025
Close Date20 Jun 2025
Listing25 Jun 2025